BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//pretalx//sciencenext.org//ifos2026//URPBK3
BEGIN:VTIMEZONE
TZID:EET
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20061029T000000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20071028T050000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10;UNTIL=20141026T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20151108T050000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=11;UNTIL=20151108T020000Z
TZNAME:EET
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
END:STANDARD
BEGIN:STANDARD
DTSTART:20160907T010000
RRULE:FREQ=YEARLY;BYDAY=1WE;BYMONTH=9
TZNAME:+03
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20060326T000000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20070325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20100328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20110328T040000
RRULE:FREQ=YEARLY;BYDAY=4MO;BYMONTH=3;UNTIL=20110328T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20120325T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20130331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20140331T040000
RRULE:FREQ=YEARLY;BYDAY=5MO;BYMONTH=3;UNTIL=20140331T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
BEGIN:DAYLIGHT
DTSTART:20150329T040000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3;UNTIL=20160327T020000Z
TZNAME:EEST
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:pretalx-ifos2026-97JEC9@sciencenext.org
DTSTART;TZID=EET:20260913T114500
DTEND;TZID=EET:20260913T121500
DESCRIPTION:<p style="margin-left: 0px!important\;">Management of recurrent
  nasopharyngeal carcinoma\, from diagnosis to potential complications.</p>
 <p style="margin-left: 0px!important\;">Locally recurrent nasopharyngeal c
 arcinoma (NPC) presents substantial challenges in clinical management so t
 hat a multimodal approach is needed. Endoscopic endonasal approach has bee
 n reported in the early 2000s as a potential treatment for selected and\, 
 nowadays\, endoscopic nasopharyngectomy is regarded as the preferred optio
 n for resectable locally recurrent NPC</p><p style="margin-left: 0px!impor
 tant\;">An italian multicenter retrospective review of patients with recur
 rent NPC\, treated with pure endoscopic approach in tertiary referral cent
 er.</p><p style="margin-left: 0px!important\;">We report an analysis of th
 e algorithm used to reach the relapse diagnosis\, how patients selection w
 as performed\, oncological results and complications related to the treatm
 ents and their management. A particular emphasis is placed upon carotid ar
 tery preoperative management and skull base osteomyelitis as a possible po
 st-operative complication.</p><p style="margin-left: 0px!important\;">Recu
 rrent NPS is a challenging disease. Only a proper patients selection and a
  360° patients management is necessary to achieve optimal oncological out
 comes</p>
DTSTAMP:20260618T223227Z
LOCATION:Laryngology 1
SUMMARY:Management of recurrent nasopharyngeal carcinoma\, from diagnosis t
 o potential complications. - Jacopo Zocchi
URL:https://sciencenext.org/ifos2026/talk/97JEC9/
END:VEVENT
END:VCALENDAR